APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icatibant Acetate Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Icatibant Acetate Injection Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchIcatibant Acetate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Icatibant Acetate Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Icatibant Acetate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icatibant Acetate Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Icatibant Acetate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icatibant Acetate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Icatibant Acetate Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Icatibant Acetate Injection market include Cipla, Eugia Pharma Specialities, Fresenius Kabi, Glenmark Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, Jiangsu Hengrui Pharmaceuticals, Sandoz and Takeda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Icatibant Acetate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Icatibant Acetate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Icatibant Acetate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Icatibant Acetate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Icatibant Acetate Injection Segment by Company

Cipla

Eugia Pharma Specialities

Fresenius Kabi

Glenmark Pharmaceuticals

Chengdu Shengnuo Biology Pharmacy

Jiangsu Hengrui Pharmaceuticals

Sandoz

Takeda Pharmaceuticals

Icatibant Acetate Injection Segment by Type

Original Drug

Generic Drug

Icatibant Acetate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Icatibant Acetate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Icatibant Acetate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Icatibant Acetate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Icatibant Acetate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Icatibant Acetate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icatibant Acetate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icatibant Acetate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icatibant Acetate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Icatibant Acetate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Icatibant Acetate Injection industry.

Chapter 3: Detailed analysis of Icatibant Acetate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Icatibant Acetate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Icatibant Acetate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Icatibant Acetate Injection Industry Trends Table 2. Icatibant Acetate Injection Industry Drivers Table 3. Icatibant Acetate Injection Industry Opportunities and Challenges Table 4. Icatibant Acetate Injection Industry Restraints Table 5. Global Icatibant Acetate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Icatibant Acetate Injection Revenue Share by Company (2021-2026) Table 7. Global Icatibant Acetate Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Icatibant Acetate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Icatibant Acetate Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Icatibant Acetate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Icatibant Acetate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Icatibant Acetate Injection Company, Product Type & Application Table 13. Global Icatibant Acetate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Icatibant Acetate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Icatibant Acetate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Icatibant Acetate Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Icatibant Acetate Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Icatibant Acetate Injection Sales Volume Share by Type (2021-2026) Table 23. Global Icatibant Acetate Injection Sales Volume Share by Type (2027-2032) Table 24. Global Icatibant Acetate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Icatibant Acetate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Icatibant Acetate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Icatibant Acetate Injection Sales Value Share by Type (2021-2026) Table 28. Global Icatibant Acetate Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global Icatibant Acetate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Icatibant Acetate Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Icatibant Acetate Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Icatibant Acetate Injection Sales Volume Share by Application (2021-2026) Table 36. Global Icatibant Acetate Injection Sales Volume Share by Application (2027-2032) Table 37. Global Icatibant Acetate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Icatibant Acetate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Icatibant Acetate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Icatibant Acetate Injection Sales Value Share by Application (2021-2026) Table 41. Global Icatibant Acetate Injection Sales Value Share by Application (2027-2032) Table 42. Global Icatibant Acetate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Icatibant Acetate Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Icatibant Acetate Injection Sales Market Share by Region (2021-2026) Table 45. Global Icatibant Acetate Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Icatibant Acetate Injection Sales Market Share by Region (2027-2032) Table 47. Global Icatibant Acetate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Icatibant Acetate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Icatibant Acetate Injection Sales Value Share by Region (2021-2026) Table 50. Global Icatibant Acetate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Icatibant Acetate Injection Sales Value Share by Region (2027-2032) Table 52. Global Icatibant Acetate Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Icatibant Acetate Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Icatibant Acetate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 58. Global Icatibant Acetate Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Icatibant Acetate Injection Sales Market Share by Country (2027-2032) Table 60. Global Icatibant Acetate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Icatibant Acetate Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Icatibant Acetate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Icatibant Acetate Injection Sales Value Market Share by Country (2027-2032) Table 64. Cipla Company Information Table 65. Cipla Business Overview Table 66. Cipla Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Cipla Icatibant Acetate Injection Product Portfolio Table 68. Cipla Recent Development Table 69. Eugia Pharma Specialities Company Information Table 70. Eugia Pharma Specialities Business Overview Table 71. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio Table 73. Eugia Pharma Specialities Recent Development Table 74. Fresenius Kabi Company Information Table 75. Fresenius Kabi Business Overview Table 76. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Fresenius Kabi Icatibant Acetate Injection Product Portfolio Table 78. Fresenius Kabi Recent Development Table 79. Glenmark Pharmaceuticals Company Information Table 80. Glenmark Pharmaceuticals Business Overview Table 81. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 83. Glenmark Pharmaceuticals Recent Development Table 84. Chengdu Shengnuo Biology Pharmacy Company Information Table 85. Chengdu Shengnuo Biology Pharmacy Business Overview Table 86. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio Table 88. Chengdu Shengnuo Biology Pharmacy Recent Development Table 89. Jiangsu Hengrui Pharmaceuticals Company Information Table 90. Jiangsu Hengrui Pharmaceuticals Business Overview Table 91. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 93. Jiangsu Hengrui Pharmaceuticals Recent Development Table 94. Sandoz Company Information Table 95. Sandoz Business Overview Table 96. Sandoz Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sandoz Icatibant Acetate Injection Product Portfolio Table 98. Sandoz Recent Development Table 99. Takeda Pharmaceuticals Company Information Table 100. Takeda Pharmaceuticals Business Overview Table 101. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 103. Takeda Pharmaceuticals Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Icatibant Acetate Injection Distributors List Table 107. Icatibant Acetate Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Icatibant Acetate Injection Product Image Figure 2. Global Icatibant Acetate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Icatibant Acetate Injection Sales (2021-2032) & (K Units) Figure 5. Global Icatibant Acetate Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Icatibant Acetate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Icatibant Acetate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Icatibant Acetate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Icatibant Acetate Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Icatibant Acetate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Icatibant Acetate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Icatibant Acetate Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Icatibant Acetate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Icatibant Acetate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Icatibant Acetate Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Icatibant Acetate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Icatibant Acetate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Icatibant Acetate Injection Sales Value Share by Application (2021-2032) Figure 26. Global Icatibant Acetate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Icatibant Acetate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Icatibant Acetate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Icatibant Acetate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Icatibant Acetate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Icatibant Acetate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Icatibant Acetate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Icatibant Acetate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Icatibant Acetate Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Icatibant Acetate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Icatibant Acetate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Icatibant Acetate Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Icatibant Acetate Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Cipla
  • Eugia Pharma Specialities
  • Fresenius Kabi
  • Glenmark Pharmaceuticals
  • Chengdu Shengnuo Biology Pharmacy
  • Jiangsu Hengrui Pharmaceuticals
  • Sandoz
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icatibant Acetate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Icatibant Acetate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Icatibant Acetate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Icatibant Acetate Injection Market Dynamics
  1. 2.1 Icatibant Acetate Injection Industry Trends
  2. 2.2 Icatibant Acetate Injection Industry Drivers
  3. 2.3 Icatibant Acetate Injection Industry Opportunities and Challenges
  4. 2.4 Icatibant Acetate Injection Industry Restraints
3 Icatibant Acetate Injection Market by Company
  1. 3.1 Global Icatibant Acetate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Icatibant Acetate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Icatibant Acetate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Icatibant Acetate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Icatibant Acetate Injection Company Ranking (2024-2026)
  6. 3.6 Global Icatibant Acetate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Icatibant Acetate Injection Company Product Type and Application
  8. 3.8 Global Icatibant Acetate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Icatibant Acetate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Icatibant Acetate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Icatibant Acetate Injection Market by Type
  1. 4.1 Icatibant Acetate Injection Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Icatibant Acetate Injection Sales Volume by Type
  5. 4.2.1 Global Icatibant Acetate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Icatibant Acetate Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Icatibant Acetate Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Icatibant Acetate Injection Sales Value by Type
  9. 4.3.1 Global Icatibant Acetate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Icatibant Acetate Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Icatibant Acetate Injection Sales Value Share by Type (2021-2032)
5 Icatibant Acetate Injection Market by Application
  1. 5.1 Icatibant Acetate Injection Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Icatibant Acetate Injection Sales Volume by Application
  6. 5.2.1 Global Icatibant Acetate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icatibant Acetate Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Icatibant Acetate Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Icatibant Acetate Injection Sales Value by Application
  10. 5.3.1 Global Icatibant Acetate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Icatibant Acetate Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Icatibant Acetate Injection Sales Value Share by Application (2021-2032)
6 Icatibant Acetate Injection Regional Sales and Value Analysis
  1. 6.1 Global Icatibant Acetate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Icatibant Acetate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Icatibant Acetate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Icatibant Acetate Injection Sales by Region (2027-2032)
  5. 6.3 Global Icatibant Acetate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Icatibant Acetate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Icatibant Acetate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Icatibant Acetate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Icatibant Acetate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Icatibant Acetate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Icatibant Acetate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Icatibant Acetate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Icatibant Acetate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Icatibant Acetate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Icatibant Acetate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Icatibant Acetate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Icatibant Acetate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Icatibant Acetate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Icatibant Acetate Injection Sales Value Share by Country, 2025 VS 2032
7 Icatibant Acetate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Icatibant Acetate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Icatibant Acetate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Icatibant Acetate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Icatibant Acetate Injection Sales by Country (2027-2032)
  6. 7.4 Global Icatibant Acetate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Icatibant Acetate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Icatibant Acetate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Icatibant Acetate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Icatibant Acetate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Icatibant Acetate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Icatibant Acetate Injection Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Eugia Pharma Specialities
  8. 8.2.1 Eugia Pharma Specialities Company Information
  9. 8.2.2 Eugia Pharma Specialities Business Overview
  10. 8.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio
  12. 8.2.5 Eugia Pharma Specialities Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Icatibant Acetate Injection Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Glenmark Pharmaceuticals
  20. 8.4.1 Glenmark Pharmaceuticals Company Information
  21. 8.4.2 Glenmark Pharmaceuticals Business Overview
  22. 8.4.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  24. 8.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 8.5 Chengdu Shengnuo Biology Pharmacy
  26. 8.5.1 Chengdu Shengnuo Biology Pharmacy Company Information
  27. 8.5.2 Chengdu Shengnuo Biology Pharmacy Business Overview
  28. 8.5.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio
  30. 8.5.5 Chengdu Shengnuo Biology Pharmacy Recent Developments
  31. 8.6 Jiangsu Hengrui Pharmaceuticals
  32. 8.6.1 Jiangsu Hengrui Pharmaceuticals Company Information
  33. 8.6.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  34. 8.6.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Icatibant Acetate Injection Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Takeda Pharmaceuticals
  44. 8.8.1 Takeda Pharmaceuticals Company Information
  45. 8.8.2 Takeda Pharmaceuticals Business Overview
  46. 8.8.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  48. 8.8.5 Takeda Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Icatibant Acetate Injection Value Chain Analysis
  2. 9.1.1 Icatibant Acetate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Icatibant Acetate Injection Sales Mode & Process
  6. 9.2 Icatibant Acetate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Icatibant Acetate Injection Distributors
  9. 9.2.3 Icatibant Acetate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst